Teva completes acquisition of Theramex from Merck Serono
This article was originally published in Scrip
Executive Summary
Teva Pharmaceutical has completed the acquisition of Theramex, Merck KGaA's European-based women's health business, just over two months after the €265 million deal was announced at the end of October 2010.